@prefix : <http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis> .
@prefix dc: <http://purl.org/dc/elements/1.1/> .
@prefix mp: <http://purl.org/mp/> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix core: <http://purl.obolibrary.org/obo/uberon/core#> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix pato: <http://purl.obolibrary.org/obo/pato#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix core1: <http://purl.obolibrary.org/obo/core#> .
@prefix terms: <http://purl.org/dc/terms/> .
@prefix uberon: <http://purl.obolibrary.org/obo/uberon#> .
@prefix subsets: <http://purl.obolibrary.org/obo/ro/subsets#> .
@prefix oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> .
@prefix OpenPVSignal: <http://purl.org/OpenPVSignal/OpenPVSignal.owl#> .
@base <http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis> .

<http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis> rdf:type owl:Ontology ;
                                                                         owl:imports <http://purl.org/OpenPVSignal/OpenPVSignal.owl> ,
                                                                                     mp: ;
                                                                         rdfs:isDefinedBy "https://apps.who.int/iris/handle/10665/255497/"^^xsd:anyURI ;
                                                                         rdfs:label "Temozolomide and Oesophagitis"^^xsd:Literal ;
                                                                         owl:versionInfo "draft-v0.95-20211109"@en .

#################################################################
#    Object Properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element
OpenPVSignal:Free_text_reporting_element rdf:type owl:ObjectProperty .


###  http://purl.org/mp/references
mp:references rdf:type owl:ObjectProperty .


###  http://purl.org/mp/supportedBy
mp:supportedBy rdf:type owl:ObjectProperty .


#################################################################
#    Individuals
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#AntitumoralsAsCausesOfOesophagitis
:AntitumoralsAsCausesOfOesophagitis rdf:type owl:NamedIndividual ,
                                             obo:OAE_0001197 ;
                                    OpenPVSignal:has_content "Medications, through different mechanisms, have also been associated with oesophagitis; particularly antitumorals " ;
                                    rdfs:label "Antitumorals as causes of oesophagitis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#ClinicalStudiesForTemozolomide
:ClinicalStudiesForTemozolomide rdf:type owl:NamedIndividual ,
                                         obo:OAE_0001197 ;
                                OpenPVSignal:refers_to_adverse_effect :oesophagitis ;
                                OpenPVSignal:refers_to_drug :temozolomide ;
                                mp:references :Ref.6 ,
                                              :Ref.7 ;
                                OpenPVSignal:has_content "In two separate clinical studies, two cases of oesophagitis associated with temozolomide were reported;6,7 it is difficult to ascertain if these cases are the ones that have been reported and stored in VigiBase®" ;
                                rdfs:label "Clinical studies for temozolomide" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#DiscussionAndConclusion
:DiscussionAndConclusion rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Conclusion ,
                                  OpenPVSignal:Discussion ;
                         mp:references :Ref.6 ,
                                       :Ref.7 ;
                         OpenPVSignal:has_content "Oesophagitis can be a serious reaction that may have many causes; among them, radiation therapy that is usually employed along with temozolomide for the treatment of brain tumours. Another cause is myelodepression and subsequent neutropenia, which in turn can give rise to infections. Medications, through different mechanisms, have also been associated with oesophagitis; particularly antitumorals. Myelodepression, for instance, can be induced by different drugs; in fact, some of the cases in the present series (1, 5, 6, 9) developed neutropenia or candidiasis. Direct damage could be another possibility, as temozolomide is administered by the oral route. Thus, based on the pathophysiology of the reaction and the mechanism of this alkylating agent, there exists the possibility that this reaction was cause-related. The present series is composed of nine cases; some of the cases (2, 3, 6, 9) come from clinical studies and are well described, as is the one from the literature (case 8). However, there is only one case (case 7) in which temozolomide is the only reported drug; since this case is not sufficiently complete, the possibility of unreported concomitants cannot be excluded. Although there is one positive dechallenge, there is no case with a positive re-challenge: based on this particular series, drawing a conclusion proves to be difficult. In the literature there are some cases of oesophagitis,6,7 but once again, it is difficult to pinpoint the reaction to temozolomide since most of the patients were being treated with multiple drugs. All in all, the best evidence could be pharmacological plausibility. Many anticancer drugs are able to interfere with the cellular cycle, and in this manner interrupt the cellular growth; this is particularly evident in rapidly growing tissues. For these drugs, stomatitis, oesophagitis, gastritis and enteritis would be a continuum depending on the route, dose and time of exposure. With this in mind, it would be expected for similar adverse reactions to occur. In fact, stomatitis, dysphagia and gastroenteritis are already labelled for temozolomide. Oesophagitis is therefore a possible reaction in connection with temozolomide. Moreover, an error in the administration could possibly account for this reaction. In fact, one of the cases mentions an “incorrect technique in drug usage process”; the SmPC does warn about this possibility: the capsules have to be swallowed as they are, with water; they must not be opened or chewed." ;
                         rdfs:label "Discussion and conclusion" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#IC025OfDecarbazineAndOesophagitis
:IC025OfDecarbazineAndOesophagitis rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component__025_(IC025)> ;
                                   OpenPVSignal:refers_to_adverse_effect :oesophagitis ;
                                   OpenPVSignal:refers_to_drug :dacarbazine ;
                                   OpenPVSignal:refers_to_information_component :ICOfDecarbazineAndOesophagitis ;
                                   OpenPVSignal:has_value 0.03 ;
                                   OpenPVSignal:refers_to_number_of_reports 7 ;
                                   rdfs:label "IC025 of decarbazine and oesophagitis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#ICOfDecarbazineAndOesophagitis
:ICOfDecarbazineAndOesophagitis rdf:type owl:NamedIndividual ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component_(IC)> ;
                                OpenPVSignal:refers_to_adverse_effect :oesophagitis ;
                                OpenPVSignal:refers_to_drug :dacarbazine ;
                                OpenPVSignal:has_value 1.29 ;
                                OpenPVSignal:refers_to_number_of_reports 7 ;
                                rdfs:label "IC of decarbazine and oesophagitis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#IntoductionContent
:IntoductionContent rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Introduction ;
                    mp:references :Ref.1 ,
                                  :Ref.2 ,
                                  :Ref.3 ;
                    OpenPVSignal:has_content "In September 2014, the UMC signal detection for the first time screened reports issued for paediatrics. This screening, using the vigiRank screening method, highlighted an association between temozolomide and oesophagitis. Since the drug is not restricted to paediatric use and multiple age groups were associated with the adverse event, this evaluation was conducted on patients of all ages. Temozolomide is an oral triazene alkylating agent that has been available since the early 2000s; coupled with radiotherapy it is the first-line treatment for glioblastoma, the most common primary brain cancer in adults, against which its efficacy has been proven.1,2 At physiological pH, temozolomide is converted to the monomethyltriazene metabolite, MTIC, which exerts the main cytotoxic action by methylating DNA at a number of sites. Temozolomide shares this metabolite and structural similarities with another triazene alkylating agent, dacarbazine.3 In early clinical development it was observed that the administration of a single dose of temozolomide induced myelosuppression. Oesophagitis is a potentially serious inflammation of the oesophagus that can occur due to different causes, from infections to physical injury resulting from radiation therapy." ;
                    rdfs:label "Intoduction content" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#LabellingOfTemozolomide
:LabellingOfTemozolomide rdf:type owl:NamedIndividual ,
                                  obo:OAE_0001197 ,
                                  OpenPVSignal:Structured_Product_Labels_information ,
                                  OpenPVSignal:Warning_Information ;
                         OpenPVSignal:refers_to_adverse_effect :dysphagia ,
                                                               :gastroenteritis ,
                                                               :stomatitis ;
                         OpenPVSignal:refers_to_drug :temozolomide ;
                         mp:references :Ref.4 ,
                                       :Ref.5 ;
                         OpenPVSignal:has_content "Temozolomide is indicated for use in children from three years of age and in adults. Oesophagitis is not labelled for the drug in adults or in children, neither in the UK SPC nor the FDA label, however, stomatitis, dysphagia and gastroenteritis are listed as adverse drug reactions.4,5" ;
                         rdfs:label "Labelling of temozolomide" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#LiteratureAndLabelling
:LiteratureAndLabelling rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Literature_information ;
                        mp:references :Ref.4 ,
                                      :Ref.5 ,
                                      :Ref.6 ,
                                      :Ref.7 ;
                        OpenPVSignal:has_content "Twelve cases of oesophagitis (WHO-ART PT) in association with temozolomide were identified in the WHO Global ICSR database, VigiBase®, in October 2014. Based on age, sex, country, type of report and other features, one duplicate (case 1) and one triplicate (case 8) have been identified. Thus, there are nine primary cases containing the reaction of interest (Table 1); in one, the reaction was reported as “oesophageal pain”. Age and sex were known in five cases while two cases only reported patient gender (Table 1). Two cases concerned children, an 8-year-old female and a 10-year-old male, while three involved male adults aged 62, 67 and 69; two cases of unknown age were female, while two cases had no information on the patient. No age or sex patterns emerge. In all cases the reaction appeared after the intake of the drug. Two reported time to onset (19 days and 31 days); in none was the reaction reported alone. Temozolomide was the only suspected drug in three of the reports. The drug was withdrawn in four cases: the outcome was unknown for two cases (1, 8), recovery as concerns one (case 2, which was reported as positive dechallenge) and no recovery in another (case 3). There is no information on dechallenge in case 7, however the outcome was recovery. No cases mention positive rechallenge. All cases except one, case 3, were considered as serious. In two cases the patient died due to severe myelosuppressive reactions. In November 2014 VigiBase® was also queried for oesophagitis (WHO-ART) in association with dacarbazine, obtaining seven cases. Additionally, this combination was highlighted through a disproportionality analysis with an IC of 1.29 and IC025 of 0.03." ;
                        rdfs:label "Literature and labelling" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Mechanism_of_temozolomide
:Mechanism_of_temozolomide rdf:type owl:NamedIndividual ,
                                    OpenPVSignal:Mechanism ;
                           mp:references :Ref.1 ,
                                         :Ref.2 ,
                                         :Ref.3 ;
                           OpenPVSignal:has_content "Temozolomide is an oral triazene alkylating agent that has been available since the early 2000s; coupled with radiotherapy it is the first-line treatment for glioblastoma, the most common primary brain cancer in adults, against which its efficacy has been proven.1,2 At physiological pH, temozolomide is converted to the monomethyl-triazene metabolite, MTIC, which exerts the main cytotoxic action by methylating DNA at a number of sites. Temozolomide shares this metabolite and structural similarities with anoth" ;
                           rdfs:label "Mechanism of temozolomide" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Oesophagitis
:Oesophagitis rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Free_text_reporting_element ;
              OpenPVSignal:refers_to_adverse_effect :oesophagitis ;
              OpenPVSignal:has_content "Oesophagitis is a potentially serious inflammation of the oesophagus that can occur due to different causes, from infections to physical injury resulting from radiation therapy" ;
              rdfs:label "Oesophagitis pathobiology" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Onset3
:Onset3 rdf:type owl:NamedIndividual ,
                 <http://www.w3.org/2006/time#DurationDescription> ;
        OpenPVSignal:has_content "31 days " ;
        <http://www.w3.org/2006/time#nominalPosition> "days" ;
        <http://www.w3.org/2006/time#numericPosition> 31 ;
        rdfs:label "Onset 3" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Onset4
:Onset4 rdf:type owl:NamedIndividual ,
                 <http://www.w3.org/2006/time#DurationDescription> ;
        OpenPVSignal:has_content "19 days " ;
        <http://www.w3.org/2006/time#nominalPosition> "days" ;
        <http://www.w3.org/2006/time#numericPosition> 19 ;
        rdfs:label "Onset 4" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#OverallReportsInVigibase
:OverallReportsInVigibase rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Reports_group ;
                          OpenPVSignal:refers_to_adverse_effect :oesophagitis ;
                          OpenPVSignal:refers_to_drug :temozolomide ;
                          OpenPVSignal:has_count 9 ;
                          OpenPVSignal:has_count_of_men 4 ;
                          OpenPVSignal:has_count_of_women 3 ;
                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                          rdfs:label "Overall reports in vigibase" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Patient1
:Patient1 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 62 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 1" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Patient2
:Patient2 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 67 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 2" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Patient3
:Patient3 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 69 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 3" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Patient4
:Patient4 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 4" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Patient5
:Patient5 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 5" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Patient6
:Patient6 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 10 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 6" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Patient7
:Patient7 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          rdfs:label "Patient 7" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Patient8
:Patient8 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 8 ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 8" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Patient9
:Patient9 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          rdfs:label "Patient 9" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#PossiblePharmacologicalPlausabilityForTemozolomideAndOesophagitis
:PossiblePharmacologicalPlausabilityForTemozolomideAndOesophagitis rdf:type owl:NamedIndividual ,
                                                                            OpenPVSignal:Adverse_Effect_Mechanism ;
                                                                   OpenPVSignal:refers_to_adverse_effect :enteritis ,
                                                                                                         :gastritis ,
                                                                                                         :oesophagitis ,
                                                                                                         :stomatitis ;
                                                                   OpenPVSignal:has_content "Many anticancer drugs are able to interfere with the cellular cycle, and in this manner interrupt the cellular growth; this is particularly evident in rapidly growing tissues. For these drugs, stomatitis, oesophagitis, gastritis and enteritis would be a continuum depending on the route, dose and time of exposure. With this in mind, it would be expected for similar adverse reactions to occur. In fact, stomatitis, dysphagia and gastroenteritis are already labelled for temozolomide. Oesophagitis is therefore a possible reaction in connection with temozolomide.  " ;
                                                                   rdfs:label "Possible pharmacological plausability for temozolomide and oesophagitis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Prof_Alfonso_Carvajal
:Prof_Alfonso_Carvajal rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Author ;
                       OpenPVSignal:has_first_name "Alfonso" ;
                       OpenPVSignal:has_last_name "Carvajal" ;
                       rdfs:label "Prof Alfonso Carvajal" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#RadiationAsCauseOfOesophagitis
:RadiationAsCauseOfOesophagitis rdf:type owl:NamedIndividual ,
                                         obo:OAE_0001182 ;
                                OpenPVSignal:refers_to_adverse_effect :oesophagitis ;
                                OpenPVSignal:has_content "Oesophagitis can be a serious reaction that may have many causes; among them, radiation therapy that is usually employed along with temozolomide for the treatment of brain tumours.  " ;
                                rdfs:label "Radiation as cause of oesophagitis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Ref.1
:Ref.1 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Newlands ES, Blackledge GR, Slack JA, Rustin GJ, Smith DB, Stuart NS, Quarterman CP, Hoffman R, Stevens MF, Brampton MH, et al. Phase I trial of temozolomide. Br J Cancer. 1992;65(2):287-91. " ;
       rdfs:label "Ref.1" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Ref.2
:Ref.2 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Cairncross G, Allgeier A, Lacombe D, Stupp R. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol. 2006;24(16):2563-9. " ;
       rdfs:label "Ref.2" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Ref.3
:Ref.3 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Audette RC, Connors TA, Mandel HG, Merai K, Ross WC. Studies on the mechanism of action of the tumour inhibitory triazenes. Biochem Pharmacol. 1973;22(15):1855-64. " ;
       rdfs:label "Ref.3" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Ref.4
:Ref.4 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "EMC SmPC for Temodal Capsules 2014. URL: https:// www.medicines.org.uk/emc/ medicine/7027. Accessed: 13 February 2015. " ;
       rdfs:label "Ref.4" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Ref.5
:Ref.5 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "FDA. Label for Temodal Capsules 2014. URL: http://www.accessdata.fda.gov/drugsatfda_d ocs/ label/2014/021029s026lbl.pdf. Accessed: 13 February 2015. " ;
       rdfs:label "Ref.5" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Ref.6
:Ref.6 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "M. R. Gilbert, P. Gaupp, V. Liu, C. Conrad, H. Colman, M. Groves, V. Puduvalli, V. Levin, S. Hsu, J. Horowitz and W. Yung. A phase I study of temozolomide (TMZ) and the farnesyltransferase inhibitor (FTI), lonafarnib (Sarazar, SCH66336) in recurrent glioblastoma. Journal of Clinical Oncology 2006 ASCO Annual Meeting Proceedings (Post-Meeting Edition); 24, No 18S (June 20 Supplement): 1556. " ;
       rdfs:label "Ref.6" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Ref.7
:Ref.7 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "M. J. van den Bent,O. Chinot, W. Boogerd, J. Bravo Marques, M. J. B. Taphoorn, J. M. Kros, C. C. D. van der Rijt, C. J. Vecht, N. De Beule, and B. Baron. Second- line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972 Ann Oncol. (2003) 14(4):599-602 doi:10.1093/annonc/mdg157. " ;
       rdfs:label "Ref.7" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Report1
:Report1 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :chestPain ,
                                               :hiatusHernia ,
                                               :myopathy ,
                                               :oesophagitis ,
                                               :oesophangeal_candidiasis ,
                                               :pancytopenia ,
                                               :thrombocytopenia ,
                                               :ulcers ,
                                               :venousThrombosis ;
         OpenPVSignal:refers_to_concomitant_drug :acetylsalicylicAcid ,
                                                 :therapeutic_radiopharmaceuticals ;
         OpenPVSignal:refers_to_patient :Patient1 ;
         OpenPVSignal:refers_to_primary_suspect_drug :temozolomide ;
         OpenPVSignal:refers_to_secondary_suspect_drug :cisplatin ,
                                                       :gemcitabine ,
                                                       :methylprednisolone ,
                                                       :paclitaxel ;
         OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "Report 1" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Report2
:Report2 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :aorticDisorder ,
                                               :chestx-rayAbnormal ,
                                               :constipation ,
                                               :erythema ,
                                               :gastro-intestinalDisorderNos ,
                                               :haematemesis ,
                                               :nausea ,
                                               :oesophagitis ,
                                               :vomiting ;
         OpenPVSignal:refers_to_concomitant_drug :amlodipine ,
                                                 :naproxen ,
                                                 :paracetamol ,
                                                 :tolterodine ,
                                                 :travoprost ,
                                                 :vitaminsNos ,
                                                 :zolpidem ;
         OpenPVSignal:refers_to_patient :Patient2 ;
         OpenPVSignal:refers_to_primary_suspect_drug :temozolomide ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         rdfs:label "Report 2" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Report3
:Report3 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :info_for_case_3 ;
         OpenPVSignal:refers_to_adverse_effect :oesophagitis ,
                                               :thrombocytopenia ;
         OpenPVSignal:refers_to_concomitant_drug :corticosteroids ,
                                                 :metamizole ,
                                                 :omeprazole ,
                                                 :therapeutic_radiopharmaceuticals ,
                                                 :tramadol ;
         OpenPVSignal:refers_to_patient :Patient3 ;
         OpenPVSignal:refers_to_primary_suspect_drug :temozolomide ;
         OpenPVSignal:time_to_onset :Onset3 ;
         OpenPVSignal:refers_to_dechallenge_outcome "negative - condition still applied" ;
         OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
         rdfs:label "Report 3" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Report4
:Report4 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :info_for_case_4 ;
         OpenPVSignal:refers_to_adverse_effect :haemoglobin ,
                                               :neutrophilCount ,
                                               :oesophagitis ,
                                               :sepsis ,
                                               :urinaryTractInfection ,
                                               :wbcAbnormalNos ;
         OpenPVSignal:refers_to_patient :Patient4 ;
         OpenPVSignal:refers_to_primary_suspect_drug :temozolomide ;
         OpenPVSignal:refers_to_secondary_suspect_drug :bevacizumab ,
                                                       :bupropion ,
                                                       :citalopram ,
                                                       :dexamethasone ,
                                                       :fexofenadine ,
                                                       :fluticasone ,
                                                       :irinotecan ,
                                                       :levothyroxine ,
                                                       :omeprazole ,
                                                       :phenytoin ,
                                                       :pindolol ,
                                                       :simvastatin ,
                                                       :therapeutic_radiopharmaceuticals ,
                                                       :tolterodine ,
                                                       :trazodone ,
                                                       <http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#paracetamol/hydrocodoneBitartrate> ;
         OpenPVSignal:time_to_onset :Onset4 ;
         rdfs:label "Report 4" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Report5
:Report5 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :febrileNeutropenia ,
                                               :mentalStatusChanges ,
                                               :mucosalInflammation ,
                                               :neoplasmProgression ,
                                               :neutropenia ,
                                               :oesophagitis ,
                                               :renalFailure ,
                                               :sepsis ,
                                               :thrombocytopenia ,
                                               :thrombosisVenousDeep ;
         OpenPVSignal:refers_to_concomitant_drug :metoprolol ,
                                                 :sertraline ;
         OpenPVSignal:refers_to_patient :Patient5 ;
         OpenPVSignal:refers_to_primary_suspect_drug :temozolomide ;
         OpenPVSignal:refers_to_secondary_suspect_drug :bevacizumab ,
                                                       :topotecan ;
         OpenPVSignal:refers_to_outcome_after_action "irrelevant death" ;
         rdfs:label "Report 5" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Report6
:Report6 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :abdominalPainUpper ,
                                               :anaemia ,
                                               :appetiteDecreased ,
                                               :febrileNeutropenia ,
                                               :mucosalInflammation ,
                                               :oesophagealPain ,
                                               :oesophagitis ,
                                               :plateletCountDecreased ;
         OpenPVSignal:refers_to_concomitant_drug :hydromorphone ;
         OpenPVSignal:refers_to_patient :Patient6 ;
         OpenPVSignal:refers_to_primary_suspect_drug :temozolomide ;
         OpenPVSignal:refers_to_secondary_suspect_drug :carboplatin ,
                                                       :cyclophosphamide ,
                                                       :etoposide ,
                                                       :irinotecan ;
         rdfs:label "Report 6" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Report7
:Report7 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :angioedema ,
                                               :incorrectTechniqueInDrugUsage ,
                                               :oesophagitis ;
         OpenPVSignal:refers_to_patient :Patient7 ;
         OpenPVSignal:refers_to_primary_suspect_drug :temozolomide ;
         OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
         rdfs:label "Report 7" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Report8
:Report8 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :dermatitis ,
                                               :leucopenia ,
                                               :oesophagitis ,
                                               :thrombocytopenia ;
         OpenPVSignal:refers_to_patient :Patient8 ;
         OpenPVSignal:refers_to_primary_suspect_drug :temozolomide ;
         OpenPVSignal:refers_to_secondary_suspect_drug :nimotuzumab ;
         OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
         OpenPVSignal:refers_to_outcome_after_action "death" ;
         OpenPVSignal:refers_to_rechallenge_outcome "unknown" ;
         rdfs:label "Report 8" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Report9
:Report9 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :dehydration ,
                                               :fatigue ,
                                               :haemorrhageNos ,
                                               :healingImpaired ,
                                               :intestinalPerforation ,
                                               :neutropenia ,
                                               :oesophagitis ,
                                               :thrombocytopenia ,
                                               :transaminaseNosIncreased ,
                                               :venousThrombosis ,
                                               :vomiting ,
                                               :woundInfection ;
         OpenPVSignal:refers_to_patient :Patient9 ;
         OpenPVSignal:refers_to_primary_suspect_drug :temozolomide ;
         OpenPVSignal:refers_to_secondary_suspect_drug :bevacizumab ;
         rdfs:label "Report 9" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#ReportsOfDacarbazineAndOesophagitis
:ReportsOfDacarbazineAndOesophagitis rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Reports_group ;
                                     OpenPVSignal:refers_to_adverse_effect :oesophagitis ;
                                     OpenPVSignal:refers_to_drug :dacarbazine ;
                                     OpenPVSignal:has_count 7 ;
                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                     rdfs:label "Reports of dacarbazine and oesophagitis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#ReportsWithDechallenge
:ReportsWithDechallenge rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Reports_group ;
                        OpenPVSignal:is_subgroup_of :OverallReportsInVigibase ;
                        OpenPVSignal:has_count 2 ;
                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                        OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
                        rdfs:label "Reports with unknown outcome of dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#ReportsWithTemozolomideAsTheOnlySuspectedDrug
:ReportsWithTemozolomideAsTheOnlySuspectedDrug rdf:type owl:NamedIndividual ,
                                                        OpenPVSignal:Reports_group ;
                                               OpenPVSignal:is_subgroup_of :OverallReportsInVigibase ;
                                               OpenPVSignal:refers_to_primary_suspect_drug :temozolomide ;
                                               OpenPVSignal:has_count 3 ;
                                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                               rdfs:label "Reports with temozolomide as the only suspected drug" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Reports_in_Vigibase
:Reports_in_Vigibase rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Free_text_reporting_element ;
                     OpenPVSignal:has_content "Twelve cases of oesophagitis (WHO-ART PT) in association with temozolomide were identified in the WHO Global ICSR database, VigiBase®, in October 2014. Based on age, sex, country, type of report and other features, one duplicate (case 1) and one triplicate (case 8) have been identified. Thus, there are nine primary cases containing the reaction of interest (Table 1); in one, the reaction was reported as “oesophageal pain”. Age and sex were known in five cases while two cases only reported patient gender (Table 1). Two cases concerned children, an 8-year-old female and a 10-year-old male, while three involved male adults aged 62, 67 and 69; two cases of unknown age were female, while two cases had no information on the patient. No age or sex patterns emerge. In all cases the reaction appeared after the intake of the drug. Two reported time to onset (19 days and 31 days); in none was the reaction reported alone. Temozolomide was the only suspected drug in three of the reports. The drug was withdrawn in four cases: the outcome was unknown for two cases (1, 8), recovery as concerns one (case 2, which was reported as positive dechallenge) and no recovery in another (case 3). There is no information on dechallenge in case 7, however the outcome was recovery. No cases mention positive rechallenge. All cases except one, case 3, were considered as serious. In two cases the patient died due to severe myelosuppressive reactions. In November 2014 VigiBase® was also queried for oesophagitis (WHO-ART) in association with dacarbazine, obtaining seven cases. Additionally, this combination was highlighted through a disproportionality analysis with an IC of 1.29 and IC025 of 0.03." ;
                     rdfs:label "Reports in Vigibase" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Reports_with_death_due_to_myelosuppressive_reaction
:Reports_with_death_due_to_myelosuppressive_reaction rdf:type owl:NamedIndividual ,
                                                              OpenPVSignal:Reports_group ;
                                                     OpenPVSignal:is_subgroup_of :OverallReportsInVigibase ;
                                                     OpenPVSignal:refers_to_adverse_effect :myelosuppression ;
                                                     OpenPVSignal:has_count 2 ;
                                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                     OpenPVSignal:refers_to_outcome_after_action "death" ;
                                                     rdfs:label "Reports with death due to myelosuppressive reaction" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Reports_with_negative_dechallenge
:Reports_with_negative_dechallenge rdf:type owl:NamedIndividual ,
                                            OpenPVSignal:Reports_group ;
                                   OpenPVSignal:is_subgroup_of :OverallReportsInVigibase ;
                                   OpenPVSignal:has_count 1 ;
                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                   OpenPVSignal:refers_to_dechallenge_outcome "negative - condition still applied" ;
                                   rdfs:label "Reports with negative dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Reports_with_positive_dechallenge
:Reports_with_positive_dechallenge rdf:type owl:NamedIndividual ,
                                            OpenPVSignal:Reports_group ;
                                   OpenPVSignal:is_subgroup_of :OverallReportsInVigibase ;
                                   OpenPVSignal:has_count 1 ;
                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                   OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
                                   rdfs:label "Reports with positive dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#RouteOfAdministrationAsTheCauseOfOesophagitis
:RouteOfAdministrationAsTheCauseOfOesophagitis rdf:type owl:NamedIndividual ,
                                                        obo:OAE_0001125 ;
                                               OpenPVSignal:has_content "Direct damage could be another possibility, as temozolomide is administered by the oral route.  " ;
                                               rdfs:label "Route of administration as the cause of oesophagitis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#SeriousReports
:SeriousReports rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Reports_group ;
                OpenPVSignal:is_subgroup_of :OverallReportsInVigibase ;
                OpenPVSignal:has_count 8 ;
                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                rdfs:label "Serious reports " .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#SummaryContent
:SummaryContent rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Summary ;
                OpenPVSignal:has_content "Temozolomide is an oral alkylating agent used in a radiation-containing regimen as the first-line treatment for glioblastoma. Oesophagitis is not listed in the EMA SmPC or FDA label, while, related reactions such as stomatitis, dysphagia and gastroenteritis are. In a series of nine cases from the WHO Global ICSR database, VigiBase®, a relationship between temozolomide and oesophagitis has been highlighted through the vigiRank screening method. Though the information coming from this series is not fully conclusive by itself and there is no clear evidence in the literature of this combination, both biological plausibility and analogy to a structurally similar drug indicate that this reaction could be correlated to temozolomide; further studies should be pursued to characterize it." ;
                rdfs:label "Summary content" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Temozolomide_and_Oesophagitis
:Temozolomide_and_Oesophagitis rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Pharmacovigilance_Signal_Report ;
                               OpenPVSignal:refers_to_author :Prof_Alfonso_Carvajal ;
                               OpenPVSignal:refers_to_signal :pvSignal ;
                               OpenPVSignal:has_creation_date "1/10/2015" ;
                               OpenPVSignal:has_overall_conclusion "causal association probable" ;
                               rdfs:label "Temozolomide and Oesophagitis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#abdominalPainUpper
:abdominalPainUpper rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "R10.10" ;
                    OpenPVSignal:has_MedDRA_code 10000087 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Abdominal pain upper" ;
                    rdfs:label "abdominal pain upper" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#acetylsalicylicAcid
:acetylsalicylicAcid rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug ;
                     OpenPVSignal:has_ATC_code "B01AC06" ,
                                               "N02BA01 " ;
                     rdfs:label "acetylsalicylic acid " .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#amlodipine
:amlodipine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C08CA01" ;
            rdfs:label "amlodipine" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#anaemia
:anaemia rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "D64.9" ;
         OpenPVSignal:has_MedDRA_code 10002034 ;
         OpenPVSignal:has_MedDRA_prefered_term "Anaemia" ;
         rdfs:label "anaemia" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#angioedema
:angioedema rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "T78.3XXA" ;
            OpenPVSignal:has_MedDRA_code 10002424 ;
            OpenPVSignal:has_MedDRA_prefered_term "Angioedema" ;
            rdfs:label "angioedema" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#anticancer_drugs
:anticancer_drugs rdf:type owl:NamedIndividual ,
                           OpenPVSignal:DrugClass ;
                  OpenPVSignal:has_mechanism :PossiblePharmacologicalPlausabilityForTemozolomideAndOesophagitis ;
                  OpenPVSignal:has_ATC_code "L01" ;
                  rdfs:label "anticancer drugs" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#aorticDisorder
:aorticDisorder rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "I77.9" ;
                OpenPVSignal:has_MedDRA_code 10058648 ;
                OpenPVSignal:has_MedDRA_prefered_term "Aortic disorder" ;
                rdfs:label "aortic disorder" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#appetiteDecreased
:appetiteDecreased rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "R63.0" ;
                   OpenPVSignal:has_MedDRA_code 10061428 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Decreased appetite" ;
                   rdfs:label "appetite decreased" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#bevacizumab
:bevacizumab rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "L01XC08" ;
             rdfs:label "bevacizumab" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#bupropion
:bupropion rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "N06AX12" ;
           rdfs:label "bupropion" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#carboplatin
:carboplatin rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "L01XA02 " ;
             rdfs:label "carboplatin" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#chestPain
:chestPain rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R07" ;
           OpenPVSignal:has_MedDRA_code 10008479 ;
           OpenPVSignal:has_MedDRA_prefered_term "Chest pain" ;
           rdfs:label "chest pain" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#chestx-rayAbnormal
:chestx-rayAbnormal rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "R91.8" ;
                    OpenPVSignal:has_MedDRA_code 10008499 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Chest X-ray abnormal" ;
                    rdfs:label "chest x-ray abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#cisplatin
:cisplatin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "L01XA01" ;
           rdfs:label "cisplatin" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#citalopram
:citalopram rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N06AB04" ;
            rdfs:label "citalopram" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#clinical_trial_info
:clinical_trial_info rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Clinical_trial_information ,
                              OpenPVSignal:Warning_Information ;
                     OpenPVSignal:refers_to_adverse_effect :myelosuppression ;
                     OpenPVSignal:refers_to_drug :temozolomide ;
                     OpenPVSignal:has_content "In early clinical development it was observed that the administration of a single dose of temozolomide induced myelosuppression." ;
                     rdfs:label "clinical trial info" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#constipation
:constipation rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "K59.0" ;
              OpenPVSignal:has_MedDRA_code 10010774 ;
              OpenPVSignal:has_MedDRA_prefered_term "Constipation" ;
              rdfs:label "constipation" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#corticosteroids
:corticosteroids rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Drug ;
                 OpenPVSignal:has_ATC_code "H02" ;
                 rdfs:label "corticosteroids" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#cyclophosphamide
:cyclophosphamide rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Drug ;
                  OpenPVSignal:has_ATC_code "L01AA01" ;
                  rdfs:label "cyclophosphamide" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#dacarbazine
:dacarbazine rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code " ‎L01AX04‎ " ;
             rdfs:label "dacarbazine" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#dehydration
:dehydration rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "E86.0" ;
             OpenPVSignal:has_MedDRA_code 10012174 ;
             OpenPVSignal:has_MedDRA_prefered_term "Dehydration" ;
             rdfs:label "dehydration" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#dermatitis
:dermatitis rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "L30.9" ;
            OpenPVSignal:has_MedDRA_code 10012431 ;
            OpenPVSignal:has_MedDRA_prefered_term "Dermatitis" ;
            rdfs:label "dermatitis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#dexamethasone
:dexamethasone rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "S02BA06" ;
               rdfs:label "dexamethasone" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#dysphagia
:dysphagia rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_MedDRA_code 10013950 ;
           OpenPVSignal:has_MedDRA_prefered_term "Dysphagia" ;
           rdfs:label "dysphagia" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#enteritis
:enteritis rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_MedDRA_code 10014866 ;
           OpenPVSignal:has_MedDRA_prefered_term "Enteritis" ;
           rdfs:label "enteritis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#errorInAdministrationOfTemozolamide
:errorInAdministrationOfTemozolamide rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Adverse_Effect_Mechanism ;
                                     OpenPVSignal:has_content "Moreover, an error in the administration could possibly account for this reaction. In fact, one of the cases mentions an “incorrect technique in drug usage process”; the SmPC does warn about this possibility: the capsules  have to be swallowed as they are, with water; they must not be opened or chewed. " ;
                                     rdfs:label "error in administration of temozolamide" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#erythema
:erythema rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "L53.9" ;
          OpenPVSignal:has_MedDRA_code 10015150 ;
          OpenPVSignal:has_MedDRA_prefered_term "Erythema" ;
          rdfs:label "erythema" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#etoposide
:etoposide rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "L01CB01 " ;
           rdfs:label "etoposide" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#fatigue
:fatigue rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "R53" ;
         OpenPVSignal:has_MedDRA_code 10016256 ;
         OpenPVSignal:has_MedDRA_prefered_term "Fatigue" ;
         rdfs:label "fatigue" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#febrileNeutropenia
:febrileNeutropenia rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "D70.9" ;
                    OpenPVSignal:has_MedDRA_code 10016288 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Febrile neutropenia" ;
                    rdfs:label "febrile neutropenia" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#fexofenadine
:fexofenadine rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "R06AX26 " ;
              rdfs:label "fexofenadine" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#fluticasone
:fluticasone rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "D07AC17" ;
             rdfs:label "fluticasone" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#gastritis
:gastritis rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_MedDRA_code 10017853 ;
           OpenPVSignal:has_MedDRA_prefered_term "Gastritis" ;
           rdfs:label "gastritis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#gastro-intestinalDisorderNos
:gastro-intestinalDisorderNos rdf:type owl:NamedIndividual ,
                                       OpenPVSignal:Adverse_Effect ;
                              OpenPVSignal:has_ICD_code "K92.9" ;
                              OpenPVSignal:has_MedDRA_code 10017944 ;
                              OpenPVSignal:has_MedDRA_prefered_term "Gastrointestinal disorder" ;
                              rdfs:label "gastro-intestinal disorder nos" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#gastroenteritis
:gastroenteritis rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_MedDRA_code 10017888 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Gastroenteritis" ;
                 rdfs:label "gastroenteritis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#gemcitabine
:gemcitabine rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "L01BC05 " ;
             rdfs:label "gemcitabine" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#glioblastoma
:glioblastoma rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Indication ;
              OpenPVSignal:has_ICD_code "C71.9" ;
              OpenPVSignal:has_MedDRA_code 10018336 ;
              OpenPVSignal:has_MedDRA_prefered_term "Glioblastoma" ;
              rdfs:label "glioblastoma" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#haematemesis
:haematemesis rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "K92.0" ;
              OpenPVSignal:has_MedDRA_code 10018830 ;
              OpenPVSignal:has_MedDRA_prefered_term "Haematemesis" ;
              rdfs:label "haematemesis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#haemoglobin
:haemoglobin rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code " D58.2" ;
             OpenPVSignal:has_MedDRA_code 10018876 ;
             OpenPVSignal:has_MedDRA_prefered_term "Haemoglobin" ;
             rdfs:label "haemoglobin" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#haemorrhageNos
:haemorrhageNos rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "D69.9" ;
                OpenPVSignal:has_MedDRA_code 10055798 ;
                OpenPVSignal:has_MedDRA_prefered_term "Haemorrhage" ;
                rdfs:label "haemorrhage nos" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#healingImpaired
:healingImpaired rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "T81.89XA" ;
                 OpenPVSignal:has_MedDRA_code 10021519 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Impaired healing" ;
                 rdfs:label "healing impaired" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#hiatusHernia
:hiatusHernia rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "K44.9" ;
              OpenPVSignal:has_MedDRA_code 10020028 ;
              OpenPVSignal:has_MedDRA_prefered_term "Hiatus hernia" ;
              rdfs:label "hiatus hernia" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#hydromorphone
:hydromorphone rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "N02AA03 " ;
               rdfs:label "hydromorphone" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#incorrectTechniqueInDrugUsage
:incorrectTechniqueInDrugUsage rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Adverse_Effect ;
                               OpenPVSignal:has_MedDRA_code 10064353 ;
                               OpenPVSignal:has_MedDRA_prefered_term "Wrong technique in drug usage process" ;
                               rdfs:label "incorrect technique in drug usage" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#info_for_case_3
:info_for_case_3 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Case_Report_Information ;
                 OpenPVSignal:has_content "Not serious" ;
                 rdfs:label "info for case 3" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#info_for_case_4
:info_for_case_4 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Case_Report_Information ;
                 OpenPVSignal:has_content "Developed oesophagitis after stopping temozolomide (duration 4 days). Sepsis." ;
                 rdfs:label "info for case 4" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#intestinalPerforation
:intestinalPerforation rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_ICD_code "K63.1" ;
                       OpenPVSignal:has_MedDRA_code 10022694 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Intestinal perforation" ;
                       rdfs:label "intestinal perforation" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#irinotecan
:irinotecan rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "L01XX19 " ;
            rdfs:label "irinotecan" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#lackOfRechallenges
:lackOfRechallenges rdf:type owl:NamedIndividual ,
                             obo:OAE_0001182 ;
                    OpenPVSignal:has_content "Although there is one positive dechallenge, there is no case with a positive re-challenge: based on this particular series, drawing a conclusion proves to be difficult.  " ;
                    rdfs:label "lack of rechallenges" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#leucopenia
:leucopenia rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "D72.819" ;
            OpenPVSignal:has_MedDRA_code 10024384 ;
            OpenPVSignal:has_MedDRA_prefered_term "Leukopenia" ;
            rdfs:label "leucopenia" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#levothyroxine
:levothyroxine rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "H03AA01" ;
               rdfs:label "levothyroxine" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#mentalStatusChanges
:mentalStatusChanges rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_ICD_code "R41.82" ;
                     OpenPVSignal:has_MedDRA_code 10048294 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Mental status changes" ;
                     rdfs:label "mental status changes" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#metamizole
:metamizole rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N02BB02" ;
            rdfs:label "metamizole" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#methylprednisolone
:methylprednisolone rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug ;
                    OpenPVSignal:has_ATC_code "D07AA01" ;
                    rdfs:label "methylprednisolone" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#metoprolol
:metoprolol rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C07AB02 " ;
            rdfs:label "metoprolol" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#mucosalInflammation
:mucosalInflammation rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_ICD_code "K52.89" ;
                     OpenPVSignal:has_MedDRA_code 10028116 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Mucosal inflammation" ;
                     rdfs:label "mucosal inflammation" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#myelosuppression
:myelosuppression rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code " D61.89" ;
                  OpenPVSignal:has_MedDRA_code 10028584 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Myelosuppression" ;
                  rdfs:label "myelosuppression" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#myopathy
:myopathy rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "G72.9" ;
          OpenPVSignal:has_MedDRA_code 10028641 ;
          OpenPVSignal:has_MedDRA_prefered_term "Myopathy" ;
          rdfs:label "myopathy" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#naproxen
:naproxen rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "M01AE02 " ;
          rdfs:label "naproxen" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#nausea
:nausea rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "R11" ;
        OpenPVSignal:has_MedDRA_code 10028813 ;
        OpenPVSignal:has_MedDRA_prefered_term "Nausea" ;
        rdfs:label "nausea" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#neoplasmProgression
:neoplasmProgression rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_ICD_code "C80.1" ;
                     OpenPVSignal:has_MedDRA_code 10061309 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Neoplasm progression" ;
                     rdfs:label "neoplasm progression" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#neutropenia
:neutropenia rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "D70.9" ;
             OpenPVSignal:has_MedDRA_code 10029354 ;
             OpenPVSignal:has_MedDRA_prefered_term "Neutropenia" ;
             rdfs:label "neutropenia" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#neutrophilCount
:neutrophilCount rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "D70.9" ;
                 OpenPVSignal:has_MedDRA_code 10029363 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Neutrophil count" ;
                 rdfs:label "neutrophil count" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#nimotuzumab
:nimotuzumab rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "L01XC" ;
             rdfs:label "nimotuzumab" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#oesophagealPain
:oesophagealPain rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code " K22.8" ;
                 OpenPVSignal:has_MedDRA_code 10030180 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Oesophageal pain" ;
                 rdfs:label "oesophageal pain" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#oesophagitis
:oesophagitis rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "K20.9" ;
              OpenPVSignal:has_MedDRA_code 10030216 ;
              OpenPVSignal:has_MedDRA_prefered_term "Oesophagitis" ;
              rdfs:label "oesophagitis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#oesophangeal_candidiasis
:oesophangeal_candidiasis rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Adverse_Effect ;
                          OpenPVSignal:has_MedDRA_code 10030154 ;
                          OpenPVSignal:has_MedDRA_prefered_term "Oesophageal candidiasis" ;
                          rdfs:label "oesophangeal candidiasis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#omeprazole
:omeprazole rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "A02BC01" ;
            rdfs:label "omeprazole" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#paclitaxel
:paclitaxel rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "L01CD01 " ;
            rdfs:label "paclitaxel" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#pancytopenia
:pancytopenia rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "D61.9" ;
              OpenPVSignal:has_MedDRA_code 10033661 ;
              OpenPVSignal:has_MedDRA_prefered_term "Pancytopenia" ;
              rdfs:label "pancytopenia" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#paracetamol
:paracetamol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "N02BE01" ;
             rdfs:label "paracetamol" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#phenytoin
:phenytoin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "N03AB02" ;
           rdfs:label "phenytoin" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#pindolol
:pindolol rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "C07AA03 " ;
          rdfs:label "pindolol" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#plateletCountDecreased
:plateletCountDecreased rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_ICD_code "D69.6" ;
                        OpenPVSignal:has_MedDRA_code 10035528 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Platelet count decreased" ;
                        rdfs:label "platelet count decreased" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#pvSignal
:pvSignal rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Signal ;
          OpenPVSignal:Free_text_reporting_element :DiscussionAndConclusion ,
                                                   :IntoductionContent ,
                                                   :Oesophagitis ,
                                                   :Reports_in_Vigibase ,
                                                   :SummaryContent ;
          OpenPVSignal:is_supported_by_individual_case_report :Report1 ,
                                                              :Report2 ,
                                                              :Report3 ,
                                                              :Report4 ,
                                                              :Report5 ,
                                                              :Report6 ,
                                                              :Report7 ,
                                                              :Report8 ,
                                                              :Report9 ;
          OpenPVSignal:is_supported_by_statistical_entity :IC025OfDecarbazineAndOesophagitis ,
                                                          :ICOfDecarbazineAndOesophagitis ,
                                                          :OverallReportsInVigibase ,
                                                          :ReportsOfDacarbazineAndOesophagitis ,
                                                          :ReportsWithDechallenge ,
                                                          :ReportsWithTemozolomideAsTheOnlySuspectedDrug ,
                                                          :Reports_with_death_due_to_myelosuppressive_reaction ,
                                                          :Reports_with_negative_dechallenge ,
                                                          :Reports_with_positive_dechallenge ,
                                                          :SeriousReports ;
          OpenPVSignal:refers_to_adverse_effect :oesophagitis ;
          OpenPVSignal:refers_to_primary_suspect_drug :temozolomide ;
          mp:supportedByData :AntitumoralsAsCausesOfOesophagitis ,
                             :ClinicalStudiesForTemozolomide ,
                             :LabellingOfTemozolomide ,
                             :RadiationAsCauseOfOesophagitis ,
                             :RouteOfAdministrationAsTheCauseOfOesophagitis ,
                             :clinical_trial_info ,
                             :lackOfRechallenges ,
                             <http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Myelodepression/subsequentNeutropenia> ;
          OpenPVSignal:initially_identified_on "1/10/2015" ;
          rdfs:label "pv signal" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#renalFailure
:renalFailure rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "N18.9" ;
              OpenPVSignal:has_MedDRA_code 10038435 ;
              OpenPVSignal:has_MedDRA_prefered_term "Renal failure" ;
              rdfs:label "renal failure" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#sepsis
:sepsis rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "A41" ;
        OpenPVSignal:has_MedDRA_code 10040047 ;
        OpenPVSignal:has_MedDRA_prefered_term "Sepsis" ;
        rdfs:label "sepsis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#sertraline
:sertraline rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N06AB06" ;
            rdfs:label "sertraline" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#simvastatin
:simvastatin rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C10AA01" ;
             rdfs:label "simvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#stomatitis
:stomatitis rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_MedDRA_code 10042128 ;
            OpenPVSignal:has_MedDRA_prefered_term "Stomatitis" ;
            rdfs:label "stomatitis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#temozolomide
:temozolomide rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_mechanism :Mechanism_of_temozolomide ,
                                         :PossiblePharmacologicalPlausabilityForTemozolomideAndOesophagitis ,
                                         :errorInAdministrationOfTemozolamide ;
              OpenPVSignal:has_ATC_code "L01AX03 " ;
              rdfs:label "temozolomide" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#therapeutic_radiopharmaceuticals
:therapeutic_radiopharmaceuticals rdf:type owl:NamedIndividual ,
                                           OpenPVSignal:Drug ;
                                  OpenPVSignal:has_ATC_code "V10" ;
                                  rdfs:label "therapeutic radiopharmaceuticals" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#thrombocytopenia
:thrombocytopenia rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "D69.6" ;
                  OpenPVSignal:has_MedDRA_code 10043554 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Thrombocytopenia" ;
                  rdfs:label "thrombocytopenia" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#thrombosisVenousDeep
:thrombosisVenousDeep rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Adverse_Effect ;
                      OpenPVSignal:has_ICD_code "I82.409" ;
                      OpenPVSignal:has_MedDRA_code 10051055 ;
                      OpenPVSignal:has_MedDRA_prefered_term "Deep vein thrombosis" ;
                      rdfs:label "thrombosis venous deep" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#tolterodine
:tolterodine rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "G04BD07" ;
             rdfs:label "tolterodine" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#topotecan
:topotecan rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "L01XX17 " ;
           rdfs:label "topotecan" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#tramadol
:tramadol rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "N02AX02" ;
          rdfs:label "tramadol" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#transaminaseNosIncreased
:transaminaseNosIncreased rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Adverse_Effect ;
                          OpenPVSignal:has_ICD_code "R74.0" ;
                          OpenPVSignal:has_MedDRA_code 10054889 ;
                          OpenPVSignal:has_MedDRA_prefered_term "Transaminases increased" ;
                          rdfs:label "transaminase nos increased" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#travoprost
:travoprost rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "S01EE04" ;
            rdfs:label "travoprost" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#trazodone
:trazodone rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "N06AX05" ;
           rdfs:label "trazodone" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#ulcers
:ulcers rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "K27.9" ;
        OpenPVSignal:has_MedDRA_code 10045285 ;
        OpenPVSignal:has_MedDRA_prefered_term "Ulcer" ;
        rdfs:label "ulcers" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#urinaryTractInfection
:urinaryTractInfection rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_ICD_code "N39.0 " ;
                       OpenPVSignal:has_MedDRA_code 10046571 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Urinary tract infection" ;
                       rdfs:label "urinary tract infection" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#usage_of_temozolomide
:usage_of_temozolomide rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Drug_Usage ;
                       OpenPVSignal:concerns_indication_for_use :glioblastoma ;
                       OpenPVSignal:refers_to_drug :temozolomide ;
                       rdfs:label "usage of temozolomide" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#venousThrombosis
:venousThrombosis rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_MedDRA_code 10047249 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Venous thrombosis" ;
                  rdfs:label "venous thrombosis" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#vitaminsNos
:vitaminsNos rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "A11" ;
             rdfs:label "vitamins nos" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#vomiting
:vomiting rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R11" ;
          OpenPVSignal:has_MedDRA_code 10047700 ;
          OpenPVSignal:has_MedDRA_prefered_term "Vomiting" ;
          rdfs:label "vomiting" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#wbcAbnormalNos
:wbcAbnormalNos rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "D72.9" ;
                OpenPVSignal:has_MedDRA_code 10061414 ;
                OpenPVSignal:has_MedDRA_prefered_term "White blood cell disorder" ;
                rdfs:label "wbc abnormal nos" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#woundInfection
:woundInfection rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "L08.9" ;
                OpenPVSignal:has_MedDRA_code 10048038 ;
                OpenPVSignal:has_MedDRA_prefered_term "Wound infection" ;
                rdfs:label "wound infection" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#zolpidem
:zolpidem rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "N05CF02" ;
          rdfs:label "zolpidem" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Myelodepression/subsequentNeutropenia
<http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#Myelodepression/subsequentNeutropenia> rdf:type owl:NamedIndividual ,
                                                                                                                       obo:OAE_0001182 ;
                                                                                                              OpenPVSignal:refers_to_adverse_effect :myelosuppression ,
                                                                                                                                                    :neutropenia ,
                                                                                                                                                    :oesophagitis ;
                                                                                                              OpenPVSignal:has_content "Another cause is myelodepression and subsequent neutropenia, which in turn can give rise to infections " ;
                                                                                                              rdfs:label "Myelodepression/subsequent neutropenia" .


###  http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#paracetamol/hydrocodoneBitartrate
<http://purl.org/OpenPVSignal/Signals/2015_5_temozolomide_oesophagitis#paracetamol/hydrocodoneBitartrate> rdf:type owl:NamedIndividual ,
                                                                                                                   OpenPVSignal:Drug ;
                                                                                                          OpenPVSignal:has_ATC_code "N02BE51" ;
                                                                                                          rdfs:label "paracetamol/hydrocodone bitartrate" .


###  Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi
